University of Minnesota Ph.D. dissertation. August 2010. Major: Biostatistics. Advisor: Bradley P. Carlin, Ph.D. 1 computer file (PDF); ix, 89 pages.Bayesian clinical trial designs offer the possibility of a substantially reduced sample size, increased statistical power, and reductions in cost and ethical hazard. However when prior and current information conflict, Bayesian methods can lead to higher than expected Type I error, as well as the possibility of a costlier and lengthier trial. We develop several models that allow for the commensurability of the information in the historical and current data to determine how much historical information is used. First, we propose methods for univariate Gaussian data and provide an example analysis...
In this research, two new designs in clinical trials are proposed. The first problem is a new Bayesi...
Includes bibliographical references (p. 123-128).The process of conducting a pharmaceutical clinical...
Background: Given the success of recent platform trials for COVID-19, Bayesian statistical methods h...
Abstract In this dissertation, Bayesian adaptive design used to identify subgroup treatment effect i...
My dissertation work primarily focuses on Bayesian adaptive design for phase I and phase II clinical...
High quality historical control data, if incorporated, may reduce sample size, trial cost and durati...
Point-of-care clinical trials are randomized clinical trials designed to maximize pragmatic design f...
[[abstract]]Basket trials evaluate a single drug targeting a single genetic variant in multiple canc...
High quality historical control data, if incorporated, may reduce sample size, trial cost, and durat...
This paper considers Bayesian approaches for incorporating information from a historical model into ...
Data of previous trials with a similar setting are often available in the analysis of clinical trial...
International audienceBACKGROUND:Performing well-powered randomised controlled trials (RCTs) of new ...
In this dissertation, we explored three Bayesian methodological extensions, including an adaptive Ba...
Obstacles sometimes limit enrollment in randomized clinical trials of an exper- imental product vers...
Hommel (Biometrical Journal; 45:581–589) proposed a flexible testing procedure for seamless phase II...
In this research, two new designs in clinical trials are proposed. The first problem is a new Bayesi...
Includes bibliographical references (p. 123-128).The process of conducting a pharmaceutical clinical...
Background: Given the success of recent platform trials for COVID-19, Bayesian statistical methods h...
Abstract In this dissertation, Bayesian adaptive design used to identify subgroup treatment effect i...
My dissertation work primarily focuses on Bayesian adaptive design for phase I and phase II clinical...
High quality historical control data, if incorporated, may reduce sample size, trial cost and durati...
Point-of-care clinical trials are randomized clinical trials designed to maximize pragmatic design f...
[[abstract]]Basket trials evaluate a single drug targeting a single genetic variant in multiple canc...
High quality historical control data, if incorporated, may reduce sample size, trial cost, and durat...
This paper considers Bayesian approaches for incorporating information from a historical model into ...
Data of previous trials with a similar setting are often available in the analysis of clinical trial...
International audienceBACKGROUND:Performing well-powered randomised controlled trials (RCTs) of new ...
In this dissertation, we explored three Bayesian methodological extensions, including an adaptive Ba...
Obstacles sometimes limit enrollment in randomized clinical trials of an exper- imental product vers...
Hommel (Biometrical Journal; 45:581–589) proposed a flexible testing procedure for seamless phase II...
In this research, two new designs in clinical trials are proposed. The first problem is a new Bayesi...
Includes bibliographical references (p. 123-128).The process of conducting a pharmaceutical clinical...
Background: Given the success of recent platform trials for COVID-19, Bayesian statistical methods h...